Perspective Therapeutics (CATX) FCF Margin Growth (3y) (2013 - 2023)
Perspective Therapeutics (CATX) FCF Margin Growth (3y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 60.00 |
| 10 | Perspective Therapeutics | 386.08 Mn | 386.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 22,034.00 |
| Sep 30, 2023 | -45,417.00 |
| Jun 30, 2023 | -53,683.00 |
| Mar 31, 2023 | -44,959.00 |
| Sep 30, 2022 | -5,588.00 |
| Jun 30, 2022 | -2,618.00 |
| Mar 31, 2022 | 2,637.00 |
| Dec 31, 2021 | 16,260.00 |
| Sep 30, 2021 | 2,711.00 |
| Mar 31, 2021 | 4,635.00 |
| Dec 31, 2020 | 7,064.00 |
| Sep 30, 2020 | 12,270.00 |
| Jun 30, 2020 | 6,892.00 |
| Mar 31, 2020 | 8,859.00 |
| Dec 31, 2019 | 10,779.00 |
| Sep 30, 2019 | 10,632.00 |
| Jun 30, 2019 | 8,774.00 |
| Mar 31, 2019 | 569.00 |
| Dec 31, 2018 | 648.00 |
| Sep 30, 2018 | -2,224.00 |